Acute-phase response patterns in isolated hepatic perfusion with tumour necrosis factor α (TNF-α) and melphalan in patients with colorectal liver metastases

European Journal of Clinical Investigation

Volumn 29, Issue 6, 1999, Pages 553-560

  De Vries, M R ^a,d   Borel Rinkes, I H M ^a,d   Swaak, A J G ^a   Hack, C E ^a,b   Van De Velde, C J H ^c   Wiggers, T ^a   Tollenaar, R A E M ^c   Kuppen, P J K ^c   Eggermont, A M M ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Department of Surgical Oncology ^*  (Netherlands)

Author keywords

Acute phase proteins; Interleukin 6; Isolated hepatic perfusion; Tumour necrosis factor

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; DEXTRAN; INTERLEUKIN 6; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; AGED; ANEMIA; ARTICLE; CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; FEMALE; FEVER; HEPATIC ARTERY; HUMAN; HYPOTENSION; INFERIOR CAVA VEIN; LIVER METASTASIS; LIVER PERFUSION; LIVER TOXICITY; LUNG TOXICITY; MALE; PORTAL VEIN; PRIORITY JOURNAL; REGIONAL PERFUSION; SHUNTING; SINUS TACHYCARDIA; THROMBOCYTOPENIA;

EID: 0032972746     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00480.x     Document Type: Article

References (34)

1. 1 Pearlmutter DH, Dinarello CA, Punsai PI, Colten HR. Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression. J Clin Invest, 1986; 78: 1349-54.
2. 2 Gauldie J, Richards C, Harnish D, et al. Interferon a2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocytestimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USAi 1987; 84: 7251-5.
3. 3 Nijsten MWN, De Groot ER, Ten Duis HJ, Klasen HJ, Hack CE, Aarden LA. Serum levels of interleukin-6 and acute phase responses. Lancet 1987; 2: 921.
4. 4 Castell JV, Gomez-Lechon MJ, David M, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989; 242: 237-9.
5. 5 Asher A, Mule JJ, Reichert CM, et al. Studies on the antitumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol 1987; 138: 963-974.
6. 6 Blick M, Sherwin SA, Rosenblum M, Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987; 47: 2986-9.
7. 7 Feinberg B, Kurzrock R, Talpa ZM, Blick M, Saks S, Gutterman JU. A phase I trial of intravenously administered recombinant tumor necrosis factor in patients with advanced cancer. J Clin Oncol 1988; 14: 2653-5.
8. 8 Benckhuijsen C, Kroon BBR, Van Geel AN, Wieberdink J. Regional perfusion treatment with melphalan for melanoma of the limb: evaluation of drug kinetics. Eur J Surg Oncol 1988; 14: 157-63.
9. 9 Lienard D, Ewalenko P, Delmotti JJ, Renard N, Lejeune FJ. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992; 10: 52-60.
10. 10 Eggermont AMM, Schraffordt Koops H, Klausner JM, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas The cumulative multicenter European experience. Ann Surg 1996; 224: 756-65.
11. 11 Eggermont AMM, Schraffordt Koops H, Lienard D, et al. Isolated Limb perfusion with high-dose tumor necrosis factor α in combination with interferon γ and Melphalan for non-resectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol 1996; 14: 2653-65.
12. 12 Borel Rinkes IHM, De Vries MR, Jonker AM, et al. Isolated hepatic perfusion in the pig with TNF-α with and without melphalan. Br J Cancer 1997; 75: 1447-53.
13. 13 Van der Veen AH, Manusama ER, Kampen van CA, et al. Tumor necrosis factor α TNF (α) in isolated kidney perfusions in rats: toxicity and anti-tumor effects. Eur J Surg Oncol 1994; 20: 404-5.
14. 14 Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89: 4845-9.
15. 15 Helle M, Be L, de Groot ER, de Vos A, Aarden LA. Sensitive ELISA for interleukin-6 Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 1991; 138: 47-56.
16. 16 Swaak AJG, Lienard D, Schraffordt Koops H, Lejeune FJ, Eggermont AMM. Effects of recombinant tumor necrosis factor α (rTNF-α) in cancer. Observations on the acute phase reaction and immunoglobulin synthesis after high-dose recombinant TNF-α administration in isolated limb perfusions in cancer patients. Eur J Clin Invest 1993; 23: 812-8.
17. 17 WHO. Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. Geneva: WHO; 1979.
18. 18 Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Chest 1993; 103: 565-75.
19. 19 Eggimann P, Chiolero R, Chassot PG, Lienard D, Gerain J, Lejeune F. Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs. Chest 1995; 107: 1074-82.
20. 20 Thom AK, Alexander R, Andrich MP, Barker WC, Rosenberg SA, Fraker DL. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor Interferon gamma and melphalan. J Clin Oncol 1995; 13: 264-73.
21. 21 Zwaveling JH, Maring JK, Clarke FL, et al. High plasma levels of tumor necrosis factor alpha and shortlived sepsis syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant tumor necrosis factor alpha interferon gamma and melphalan. Crit Care Med 1996; 24: 765-70.
22. 22 Martin LF, Var TC, Davied PK, Munger BL, Lynch JC, Spangler S, Remick DG. Intravascular plastic catheters: how they potentiate tumor necrosis factor release and exacerbate complications associated with sepsis. Arch Surg 1991; 126: 1087-93.
23. 23 Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993; 105: 25.
24. 24 Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg 1902; 79: 757-60.
25. 25 Shenkin A, Fraser WD, Series J, et al. The serum IL-6 response to elective surgery. Lymphokine Res 1989; 8: 123-7.
26. 26 Crozier TA, Muller JE, Quittkat D, Sydow M, Wuttke W, Kettler D. Effect of anaesthesia on the cytokine response to abdominal surgery. Br J Anaesth 1994; 72: 280-5.
27. 27 Nishimoto N, Yoshizaki K, Tagoh H, et al. Elevation of serum interleukin-6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 1989; 50: 399-401.
28. 28 Ohzato H, Yoshizaki K, Nishimotot N, et al. Interleukin-6 as a, new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery, Surgery 1992; 111: 201-9.
29. 29 Cruickshank AM, Fraser WD, Burns HJG, et al. Response of serum interleukin-6 in patients undergoing elective surgery of various severity. Clin Sci 1990; 79: 757-60.
30. 30 Swaak AJG, Van Rooyen A, Nieuwenhuis F, Aarden LA, Interleukin-6 (IL-6) in the synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 1988; 17: 469-74.
31. 31 Murata A, Ogawa M, Yasuda T, et al. Serum interleukin-6 C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) or acute phase reactants after major thoraco-abdominal surgery. Immunol Invest 1990; 19: 271-8.
32. 32 Pullicino EA, Carli F, Poole S, Rafferty B, Malik ST, Elia M. The relationship between the circulating concentrations of interleukin-6 (IL-6) tumor necrosis factor α (TNFα) and the acute phase response to elective surgery and accidental surgery. Lymphokine Res 1990; 9: 231-8.
33. 33 Moore CM, Desborough JP, Powell H, Burrin JM, Hall GM. Effects of extradural anaesthesia on interleukin-6 and acute phase response to surgery. Br J Anaesth 1994; 72: 272-9.
34. 34 Borel Rinkes IHM, Bader A, Closs EI, et al. A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes. Biotechnol Prog 1992; 8: 219-25.